Here are a few of the most interesting Assertio Therapeutics statistics and facts I was able to dig up. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Please note that some of these numbers are easier to find than others. A few of these Assertio Therapeutics stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%
Assertio Therapeutics Facts
- Website: www.assertiotx.com
- Year Founded: 1995 (as Depomed)
- Headquarters: Newark, CA
- CEO: Arthur Higgins
Assertio Therapeutics Statistics
Number of Assertio Therapeutics employees:
Last updated 2/1/20
Assertio Therapeutics annual revenue:
- 2019: $229 million
- 2018: $311 million
- 2017: $380 million
- 2016: $455 million
- 2015: $342 million
Assertio Therapeutics annual net income:
- 2019: $217 million net loss
- 2018: $36 million
- 2017: $102 million net loss
- 2016: $88 million net loss
- 2015: $75 million net loss